Insider · CIK 0001721685

Kennedy Eugene P.

Reports to the SEC for 2 companies · AMES, IA

sec.gov

Transactions

Companies

Filings

CIK

0001721685

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-02-25	GRTXGalera Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+55K sh	—	—	55,000
2022-09-01	GRTXGalera Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+150K sh	—	—	150,000
2021-02-01	LUMOS PHARMA, INC.A Award	Chief Medical Officer	AAward	+939 sh	—	—	11,423
2021-02-01	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+31.5K sh	—	—	31,475
2020-04-01	LUMOS PHARMA, INC.A Award	Chief Medical Officer	AAward	+9,000 sh	—	—	10,484
2020-04-01	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+45K sh	—	—	45,000
2020-01-04	LUMOS PHARMA, INC.F Tax Payment	Chief Medical Officer	FTax Payment	−376 sh	$2.21	−$830.96	13,721
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−50K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+16.7K sh	—	—	16,667
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	+50K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+11.9K sh	—	—	11,944
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+4,724 sh	—	—	4,724
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−30K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+7,032 sh	—	—	7,032
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+469 sh	—	—	469
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−10K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−37.5K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+7,813 sh	—	—	7,813
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+6,641 sh	—	—	6,641
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+4,297 sh	—	—	4,297
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−110K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+9,167 sh	—	—	9,167
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+15.9K sh	—	—	15,889
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+6,875 sh	—	—	6,875
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+6,875 sh	—	—	6,875
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+4,587 sh	—	—	4,587
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+4,582 sh	—	—	4,582
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+4,582 sh	—	—	4,582
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+2,445 sh	—	—	2,445
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+2,326 sh	—	—	2,326
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+174 sh	—	—	174
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−10K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+2,188 sh	—	—	2,188
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+313 sh	—	—	313
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−12.6K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+2,525 sh	—	—	2,525
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+330 sh	—	—	330
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+241 sh	—	—	241
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+66 sh	—	—	66
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−50K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+24.3K sh	—	—	24,306
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+695 sh	—	—	695
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−50K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+15.6K sh	—	—	15,625
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+4,550 sh	—	—	4,550
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+4,826 sh	—	—	4,826
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−1,000 sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+250 sh	—	—	250
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+177 sh	—	—	177
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+73 sh	—	—	73

Recent filings

Accepted (ET)
Feb 284
Kennedy Eugene P.0000899243-23-006469
SEC(opens sec.gov)
Sep 24
Kennedy Eugene P.0000899243-22-030285
SEC(opens sec.gov)
Feb 34
Kennedy Eugene P.0001126234-21-000008
SEC(opens sec.gov)
Apr 34
Kennedy Eugene P.0001126234-20-000045
SEC(opens sec.gov)
Jan 64
Kennedy Eugene P.0001126234-20-000006
SEC(opens sec.gov)
Aug 24
Kennedy Eugene P.0001126234-19-000107
SEC(opens sec.gov)
Aug 24
Kennedy Eugene P.0001126234-19-000108
SEC(opens sec.gov)

Companies

Address

C/O NEWLINK GENETICS CORPORATION 2503 SOUTH LOOP DR., SUITE 5100

AMES, IA, 50010